Loading...
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
Soft tissue sarcomas (STSs) are aggressive tumors with few efficient systemic therapies. Poly(ADP‐ribose) polymerase‐1 (PARP1) inhibitors represent an emerging therapeutic option in tumors with genomic instability. The genomics of STSs is complex in more than half of cases, suggesting a high level o...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599836/ https://ncbi.nlm.nih.gov/pubmed/31131495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12522 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|